Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of February 28, 2026, United Therapeutics Corporation (UTHR) has a Wall Street consensus price target of $563.17, based on estimates from 30 covering analysts. With the stock currently trading at $503.90, this represents a potential upside of +11.8%. The company has a market capitalization of $21.99B.
Analyst price targets range from a low of $447.00 to a high of $645.00, representing a 35% spread in expectations. The median target of $581.00 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 15 analysts rating the stock as a Buy or Strong Buy,14 rating it Hold, and 1 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, UTHR trades at a trailing P/E of 18.1x and forward P/E of 16.9x. The forward PEG ratio of 0.88 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow +7.0% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $664.44, with bear and bull scenarios of $-64.09 and $966.45 respectively. Model confidence stands at 39/100, suggesting limited visibility into future performance.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how UTHR stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonUnited Therapeutics Corporation (UTHR) has a consensus 12-month price target of $563.17, implying 11.8% upside from $503.9. The 30 analysts covering UTHR see moderate appreciation potential.
UTHR has a consensus rating of "Buy" based on 30 Wall Street analysts. The rating breakdown is mixed, with 14 Hold ratings making up the largest segment. The consensus 12-month price target of $563.17 implies 11.8% upside from current levels.
With a forward P/E of 16.8988x, UTHR trades at a relatively low valuation. The consensus target of $563.17 implies 11.8% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $645 for UTHR, while the most conservative target is $447. The consensus of $563.17 represents the median expectation. Our quantitative valuation model projects a bull case target of $966 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
UTHR is heavily covered by Wall Street, with 30 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 15 have Buy ratings, 14 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month UTHR stock forecast based on 30 Wall Street analysts shows a consensus price target of $563.17, with estimates ranging from $447 (bear case) to $645 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $664, with bear/bull scenarios of $-64/$966.
Our quantitative valuation model calculates UTHR's fair value at $664 (base case), with a bear case of $-64 and bull case of $966. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 39/100.
UTHR trades at a forward P/E ratio of 16.9x based on next-twelve-months earnings estimates compared to a trailing P/E of 18.1x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are optimistic on UTHR, with a "Buy" consensus rating and $563.17 price target (11.8% upside). 15 of 30 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
UTHR analyst price targets range from $447 to $645, a 35% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $563.17 consensus represents the middle ground. Our model's $-64-$966 range provides an independent fundamental perspective.